Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM AGILE Trial

LOS ANGELES--(BUSINESS WIRE)--GCAR, Kazia, and Kintara Announce Commencement of Kazia’s paxalisib and Kintara’s VAL-083 in GBM AGILE

Click to view original post